Evidence mapPaperPMID 33546259Full record

ReviewJournal of clinical medicine2021

Recurrent Gestational Diabetes Mellitus: A Narrative Review and Single-Center Experience.

Aoife M Egan, Elizabeth Ann L Enninga, Layan Alrahmani, Amy L Weaver, Michael P Sarras, Rodrigo Ruano

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Article
  3. Preconception Perceptions, Knowledge and Behaviours of Women With Gestational Diabetes Mellitus: A Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Beta-cell compensation and gestational diabetes.The Journal of biological chemistry · 2023
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aoife M EganDepartment of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-0379-9279
Elizabeth Ann L EnningaDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-3621-7335
Layan AlrahmaniDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA.
Amy L WeaverDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Michael P SarrasDepartment of Cell Biology and Anatomy, Rosalind Franklin University of Medicine and Science, Chicago, IL 60064, USA.ORCID 0000-0001-7151-527X
Rodrigo RuanoDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-3642-5858

Funding

NICHD NIH HHS K12 HD065987NIH HHS DK092721 and HD065987
6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is a frequently observed complication of pregnancy and is associated with an elevated risk of adverse maternal and neonatal outcomes. Many women with GDM will go on to have future pregnancies, and these pregnancies may or may not be affected by GDM. We conducted a literature search, and based on data from key studies retrieved during the search, we describe the epidemiology of GDM recurrence. This includes a summary of the observed clinical risk factors of increasing maternal age, weight, ethnicity, and requirement for insulin in the index pregnancy. We then present our data from Mayo Clinic (January 2013-December 2017) which identifies a GDM recurrence rate of 47.6%, and illustrates the relevance of population-based studies to clinical practice. Lastly, we examine the available evidence on strategies to prevent GDM recurrence, and note that more research is needed to evaluate the effect of interventions before, during and after pregnancy.

Indexed as

GDMgestational diabetesglucose intolerancepregnancyrecurrence

Identifiers

PMID33546259
PMCPMC7913262

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.